The emerging approach of the medication represents a significant development in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – the GLP-1 hormone and the GIP hormone https://tirzepatidepeptide193692.tribunablog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56734080